- Approval Id
- 9c4814e84ba53855
- Drug Name
- TYPHIM VI INJECTION 0.025 mg/0.5 ml
- Product Name
- TYPHIM VI INJECTION 0.025 mg/0.5 ml
- Approval Number
- SIN08481P
- Approval Date
- 1995-12-16
- Registrant
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
- Licence Holder
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION
- Dosage
- <p><strong>4.2 Posology and method of administration</strong></p>
<p><strong><u>Posology</u></strong></p>
<p>RESTRICTED TO ADULTS AND CHILDREN OVER 2 YEARS OF AGE.</p>
<p>A single injection of 0.5 ml. If exposure to risk continues and depending on the level of exposure, revaccination will be performed every 2–3 years.</p>
<p><u><em>Paediatric population</em></u></p>
<p>The vaccination schedule is the same for children and for adults.</p>
<p><strong><u>Method of administration</u></strong></p>
<p>Intramuscular or subcutaneous route</p>
- Route Of Administration
- SUBCUTANEOUS, INTRAMUSCULAR
- Indication Info
- <p><strong>4.1 Therapeutic indications</strong></p>
<p>Prevention of typhoid fever in adults and in children over 2 years of age, and especially: travellers to endemic areas, migrants, health care professionals and military personnel.</p>
- Contraindications
- <p><strong>4.3 Contraindications</strong></p>
<p>Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 to formaldehyde or to casein (which may be present as traces in each dose, owing to their use during the manufacturing process) – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>.</p>
<p>Vaccination should be postponed in case of acute febrile disease.</p>
- Atc Code
- J07AP03
- Atc Item Name
- typhoid, purified polysaccharide antigen
- Pharma Manufacturer Name
- SANOFI-AVENTIS SINGAPORE PTE. LTD.
